TAG:
cap
More IVD Consolidation: DPC Sells to Siemens
CEO SUMMARY: It is a significant acquisition, and not just because Diagnostic Products Corporation has a major presence in immunodiagnostics. Siemens Medical Solutions is one of the dominant competitors in radiology. Its willingness to pony up almost $2 billion t…
May 22, 2006 “Intelligence: Late Breaking Lab News”
Another investment firm has acquired an anatomic pathology company. It was announced today that Water Street Capital Partners of Chicago, Illinois, has acquired a majority ownership in Lakewood Pathology Associates, located in Lakewood, New Jersey. Under new ownershi…
Conference Speeches Offer Useful Insights
CEO SUMMARY: There is an interesting dichotomy between Asia and North America. The same problems and challenges exist in both regions—declining reimbursement and budgets, labor force issues, and the need to spend more for new diagnostic technology. Yet laboratories in both regions see a…
Tour of Korean Labs Has Plenty to Teach
CEO SUMMARY: Faster turnaround times and better quality seem to be some common motivations for installing automation in the three Korean labs visited by THE DARK …
Lab Automation Pioneer Assesses Outcomes
CEO SUMMARY: Debate has dogged the subject of laboratory automation since its earliest days. That was true during the early 1990s in Japan. It was true in Canada and the United States throughout the 1990s. It is still true in this decade. That is why it was startling to hear a founding fa…
May 1, 2006 “Intelligence: Late Breaking Lab News”
Lots of news unfolding across the lab industry. Here’s a round-up of recent and noteworthy items: NEW VENTURES • Persistent rumors indicate that a new national ana…
CYP450 Testing To Have Major Clinical Impact
CEO SUMMARY: Pharmacogenomics, companion diagnostics, “personalized prescription drug therapy”—by any name, use of molecular diagnostics to guide clinicians in the prescribing and dosing of drugs is about to expand exponentially. Some experts predict that CYP450 testing alone will …
CYP450 Plays Major Role In Drug Metabolization
CEO SUMMARY: Each year, over 100 million new prescriptions are written for two classes of drugs with metabolic pathways affected by genetic variations in cytochrome P450. There are strong clinical arguments in favor of testing individuals for these genetic mutations to determine whether t…
Placenta Registry Stirs Unwarranted Controversy
CEO SUMMARY: On the surface, the “exposé” published by The Oregonian newspaper on February 12 seemed designed to sensationalize an effort by local obstetricians, hospitals, and pathologists to do a better job of evaluating placentas taken from patients who had experienced a difficult…
Victorville Community Hospital, Quest Diagnostics, ASCP, MIME
ASCP ACQUIRES MIME’S CYTOLOGY TRAINING AND PROFICIENCY TESTING IT WAS A BIG BREAK for pathologists and cytotechnologists involved in Pap testing. In a deal announced at the end of February, the American Society for Clinical Pathology (ASCP) has acquired “the complete cyt…
CURRENT ISSUE
Volume XXXII, No. 12 – August 25, 2025
In an exclusive interview, a laboratory industry M&A specialist discusses what’s driving lab outreach sales to national lab companies. Also, The Dark Report analyzes ways in which pathology and clinical labs can profitably partner with pharmaceutical companies.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.